$195

GLP3-R 20MG

This research only product is supplied in a 3ml vial containing 20mg of GLP-3 as a lyophilized powder.  Every compound undergoes stringent independent 3rd party testing in a US laboratory with verified 99%+ purity and QR link to the COA stamped on the vial

Additional information

GLP-3 is an investigational triple-agonist peptide that targets three key receptors simultaneously: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon. This multi-target approach distinguishes it from single-agonist therapies (e.g., semaglutide, which primarily hits GLP-1) and positions it within emerging research on multi-receptor agonists for metabolic studies. It's designed for laboratory in vitro research only, not human or veterinary use, as emphasized in its labeling and regulatory status under 21 CFR Parts 100-740.

Early scientific literature suggests that GLP-3 may produce robust reductions in body weight, enhance insulin sensitivity, and influence lipid metabolism more significantly than single-pathway agonists. Its glucagon-receptor engagement also makes it a candidate for investigating thermogenesis, fat oxidation, and hepatic metabolic pathways.